Does RISANKIZUMAB-RZAA Cause Skin plaque? 278 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 278 reports of Skin plaque have been filed in association with RISANKIZUMAB-RZAA. This represents 0.4% of all adverse event reports for RISANKIZUMAB-RZAA.
278
Reports of Skin plaque with RISANKIZUMAB-RZAA
0.4%
of all RISANKIZUMAB-RZAA reports
0
Deaths
19
Hospitalizations
How Dangerous Is Skin plaque From RISANKIZUMAB-RZAA?
Of the 278 reports, 19 (6.8%) required hospitalization.
Is Skin plaque Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 278 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Skin plaque?
SECUKINUMAB (2,073)
ETANERCEPT (778)
OMALIZUMAB (607)
ADALIMUMAB (597)
METHOTREXATE (535)
CYCLOSPORINE (276)
CLOBETASOL (227)
DUPILUMAB (200)
TRIAMCINOLONE (156)
INFLIXIMAB (146)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Skin plaque Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA